The SPPL3-defined glycosphingolipid repertoire regulates immune responses by improving HLA class I access
Authors:
- Marlieke L.M. JongsmaMJMarlieke L.M. Jongsma
- Matthijs RaabenMRMatthijs Raaben
- Antonius A. de WaardAWAntonius A. de Waard
- Tao ZhangTZTao Zhang
- Birol CabukustaBCBirol Cabukusta
- Vincent A. BlomenVBVincent A. Blomen
- Anastasia XagaraAnastasia Xagara
- Tamara VerkerkTVTamara Verkerk
- Lennert JanssenLJLennert Janssen
- Elmer StickelESElmer Stickel
Preprint
Abstract
Summary: HLA class I (HLA-I) drives immune responses by presenting antigen-derived peptides to cognate CD8 + T cells. This process is often hijacked by tumors and pathogens for immune evasion. Since therapeutic options for restoring HLA-I antigen presentation are limited, we aimed to identify new HLA-I pathway targets. By iterative genome-wide screens we uncovered that the cell surface glycosphingolipid (GSL) repertoire determines effective HLA-I antigen presentation. We show that absence of the protease SPPL3 augments B3GNT5 enzyme activity, resulting in upregulated levels of surface (neo)lacto-series GSLs. These GSLs sterically impede molecular interactions with HLA-I and diminish CD8 + T cell activation. In accordance, a disturbed SPPL3-B3GNT5 pathway in glioma associates with decreased patient survival. Importantly, we show that this immunomodulatory effect can be reversed through GSL synthesis inhibition using clinically approved drugs. Overall, our study identifies a GSL signature that functionally inhibits antigen presentation and represents a potential therapeutic target in cancer, infection and autoimmunity.Keywords
All Related Versions
- Published version: Immunity, 54 (1), 132.
This publication has 109 references indexed in Scilit:
- Crystal structure of adenovirus E3-19K bound to HLA-A2 reveals mechanism for immunomodulationNature Structural & Molecular Biology, 2012
- Overview of theCCP4 suite and current developmentsActa Crystallographica Section D Structural Biology, 2011
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in CancerNucleic Acids Research, 2010
- The quality control of MHC class I peptide loadingCurrent Opinion in Cell Biology, 2008
- Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysisJournal of Experimental Medicine, 2008
- Differential Regulation of GM1 and Asialo-GM1 Expression by T Cells and Natural Killer (NK) Cells in Respiratory Syncytial Virus InfectionViral Immunology, 2008
- Structure and function of glycosphingolipids and sphingolipids: Recollections and future trendsBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyJournal of Experimental Medicine, 2006
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- The Protein Data BankNucleic Acids Research, 2000